{
  "attach_pages": "5",
  "attach_size": "788",
  "attach_type": "0",
  "attach_url": "https://pdf.dfcfw.com/pdf/H3_AP202001141374160055_1.pdf?1579017548000.pdf",
  "company_code": "80000118",
  "eitime": "2020-01-14 15:59:08",
  "extend": {},
  "info_code": "AP202001141374160055",
  "language": "0",
  "notice_date": "2020-01-14 00:00:00",
  "notice_title": "【粤开医药公司事件点评】天坛生物：全年业绩符合预期，主要血制产品批签发量同比大增",
  "page_size": 1,
  "page_size_ch": 0,
  "page_size_cht": 0,
  "page_size_en": 0,
  "rating": "BB",
  "researcher": "李志新",
  "security": [
    {
      "market_uni": "1",
      "publish_relation": [
        {
          "originalCode": "1044",
          "publishName": "生物制品"
        }
      ],
      "short_name": "天坛生物",
      "short_name_ch": "天坛生物",
      "short_name_cht": "天壇生物",
      "short_name_en": "BTBP",
      "stock": "600161"
    }
  ],
  "short_name": "天坛生物",
  "source_sample_name": "粤开证券",
  "star": "3"
}